Gerr F, Frumkin H, Hodgins P
Division of Environmental and Occupational Health, Emory University School of Public Health, Atlanta, GA 30329.
J Toxicol Clin Toxicol. 1994;32(5):569-75. doi: 10.3109/15563659409011061.
Because of its favorable side effects profile, the oral chelating agent dimercaptosuccinic acid is often used for treatment of lead intoxication. We report a case of a 45-year-old black male with glucose-6-phosphate dehydrogenase deficiency and a 17 year history of occupational lead exposure who developed hemolysis during treatment with dimercaptosuccinic acid for symptomatic lead intoxication.
